Vor Bio to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Vor Bio, a clinical-stage cell and genome engineering company, will participate in upcoming investor conferences, including Citizens JMP Life Sciences Conference and H.C. Wainwright 2nd Annual BioConnect Investor Conference. The company aims to engage with investors and showcase its progress and potential.
Positive
- None.
Negative
- None.
CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:
The Citizens JMP Life Sciences Conference
Fireside Chat: Tuesday, May 14, 2024 at 11:00 am ET
Location: New York, NY
A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.
H.C. Wainwright 2nd Annual BioConnect Investor Conference
Fireside Chat: Monday, May 20, 2024 at 10:30 am ET
Location: New York, NY
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com
FAQ
When will Vor Bio participate in the Citizens JMP Life Sciences Conference?
Where can investors access the webcast of the fireside chat at the Citizens JMP Life Sciences Conference?
When will Vor Bio participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference?
